Emcure Pharmaceuticals to Acquire Remaining Stake in its Subsidiary, Zuventus Healthcare Ltd. administrator admin Date 23 June, 2025 Share: Prev Emcure Pharmaceuticals Achieves Robust Q4FY25 Performance with 19% Revenue Growth and 63% Profit After Tax Growth